| Mrs Melynda Kay Lamotte, MS CCC-SLP | |
|
440 32nd St, West Palm Beach, FL 33407-4810 | |
| (561) 889-4622 | |
| Not Available |
| Full Name | Mrs Melynda Kay Lamotte |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 440 32nd St, West Palm Beach, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023143880 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SA 6773 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Melynda Kay Lamotte, MS CCC-SLP 440 32nd St, West Palm Beach, FL 33407-4810 Ph: () - | Mrs Melynda Kay Lamotte, MS CCC-SLP 440 32nd St, West Palm Beach, FL 33407-4810 Ph: (561) 889-4622 |
News Archive
The future of pediatric and perinatal palliative care should include accepting parents' need for proximity to the child, combining the strategies of palliative and intensive care physicians, improving healthcare providers' listening skills, and involving multiple disciplines, recommend researchers.
Sunovion Pharmaceuticals Inc. today announced that a study evaluating the efficacy and safety of dasotraline in adults with moderate to severe binge eating disorder met its primary endpoint, demonstrating a statistically significant decrease in number of binge days per week from baseline to Week 12 in the group treated with dasotraline 6 mg/day versus the placebo-treated group.
Patients with esophageal cancer who survive 5 years after undergoing surgery might breathe a sigh of relief and become complacent about continued monitoring. In fact, there is little published information on the outcome of patients with locally advanced esophageal cancer (LAEC) who survive beyond the 5-year mark.
Dyax Corp. announced today that the European Medicines Agency (EMA) has completed its validation process for the Marketing Authorization Application (MAA) for potential approval to market DX-88 (ecallantide) in the European Union (EU).
› Verified 9 days ago
Hannah Mallen, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5589 Okeechobee Blvd, West Palm Beach, FL 33417 Phone: 224-303-1400 | |
Mr. Steve Francis Mikita, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1626 Davis Rd, West Palm Beach, FL 33406 Phone: 561-439-8897 | |
Danielle Laskey Wallace, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2401 Country Oaks Ln, West Palm Beach, FL 33410 Phone: 561-862-7793 | |
Alyssa Savery, M.S. CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6414 13th Rd S, Suite 200, West Palm Beach, FL 33415 Phone: 561-478-9900 | |
Samantha Kirby, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5205 Village Blvd, West Palm Beach, FL 33407 Phone: 561-436-8458 | |
Bilingual Therapies For Children And Adults, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2393 S Congress Ave, Suite 200, West Palm Beach, FL 33406 Phone: 561-253-0422 Fax: 561-649-0210 |